Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia

Clinical trial NCT06047262 · RECRUITING

Trial details

NCT number: NCT06047262
Sponsor: Marc Donath
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2024-07-09
Primary completion: 2028-07-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.